JJ, M., M, G., JF, M., SA, D., PC, T., SC, R., . . . J, H. (2022). Differences in B-Cell Immunophenotypes and Neutralizing Antibodies Against SARS-CoV-2 After Administration of BNT162b2 (Pfizer-BioNTech) Vaccine in Individuals with and without Prior COVID-19 - A Prospective Cohort Study. Journal of Inflammation Research, ume 15, 4449-4466.
Chicago-referens (17:e uppl.)JJ, Morales-Núñez, García-Chagollán M, Muñoz-Valle JF, Díaz-Pérez SA, Torres-Hernández PC, Rodríguez-Reyes SC, Santoscoy-Ascencio G, Sierra García de Quevedo JJ, och Hernández-Bello J. "Differences in B-Cell Immunophenotypes and Neutralizing Antibodies Against SARS-CoV-2 After Administration of BNT162b2 (Pfizer-BioNTech) Vaccine in Individuals with and Without Prior COVID-19 - A Prospective Cohort Study." Journal of Inflammation Research ume 15 (2022): 4449-4466.
MLA-referens (9:e uppl.)JJ, Morales-Núñez, et al. "Differences in B-Cell Immunophenotypes and Neutralizing Antibodies Against SARS-CoV-2 After Administration of BNT162b2 (Pfizer-BioNTech) Vaccine in Individuals with and Without Prior COVID-19 - A Prospective Cohort Study." Journal of Inflammation Research, vol. ume 15, 2022, pp. 4449-4466.
